A5022134084- Prenatal Substance Exposure Effects
- Maternal Mental Health During Pregnancy and Postpartum
- Gestational Diabetes Research and Management
- Infant Development and Preterm Care
- Neonatal Health and Biochemistry
- Prenatal Screening and Diagnostics
- Renal and related cancers
- Parvovirus B19 Infection Studies
Brigham and Women's Hospital
2018
Harvard University
2018
Tufts Medical Center
2015-2017
Tufts University
2017
<b>Objectives</b> To assess the impact of in utero co-exposure to psychotropic medications and opioids on incidence severity neonatal drug withdrawal. <b>Design</b> Observational cohort study. <b>Setting</b> Nationwide sample pregnancies publicly insured women US, nested Medicaid Analytic eXtract (2000-10). <b>Participants</b> 201 275 pregnant with public insurance who were exposed around time delivery their liveborn infants. <b>Interventions</b> In exposure...
( BMJ . 2017;358:j3326) Neonatal abstinence syndrome is a recognized complication of intrauterine exposure to opioids. can manifest in number different ways, from difficulty feeding and sleeping more severe complications such as impaired thermoregulation, seizures, failure thrive, respiratory distress. Because pregnant women who are using an opioid often also use psychotropic medications, there concerns about potential interactions between the drugs leading increase occurrence severity...